Chiu-Yueh Chen

Title: Innovations in Osteoporosis Treatment by Inventor Chiu-Yueh Chen

Introduction

Chiu-Yueh Chen is a notable inventor based in Tainan, Taiwan, recognized for his contributions to medical research, particularly in the field of osteoporosis and angiogenesis-related diseases. With one patent to his name, his work exemplifies the innovative spirit that drives advancements in healthcare.

Latest Patents

Chiu-Yueh Chen's patent focuses on "Disintegrin Variants and Their Use in Treating Osteoporosis-Induced Bone Loss and Angiogenesis-Related Diseases." This innovative patent discloses disintegrin variants that include isolated polypeptides exhibiting integrin αvβ3 receptor-antagonist activity while showing significantly reduced blocking activity on integrin αIIbβ3 and/or α5β1 compared to wild-type disintegrins. The uniqueness of this variant is its capacity to treat and prevent αvβ3 integrin-associated diseases in mammals, including osteoporosis, tumors, cancer growth, and various angiogenesis-related eye conditions. By modifying the disintegrin nucleotide sequence, these polypeptides display a substantially lower affinity for integrin αIIbβ3 and/or α5β1, making them potentially more effective for therapeutic applications.

Career Highlights

Throughout his career, Chiu-Yueh Chen has been associated with prestigious institutions such as National Cheng Kung University and National Taiwan University. His research aims not only to enhance our understanding of osteoporosis but also to innovate new treatments for related ailments that affect millions globally.

Collaborations

Chiu-Yueh Chen's work has been enriched through collaborations with esteemed colleagues, including Woei-Jer Chuang and Wen-Mei Fu. This teamwork fosters an environment of creativity and innovation, enabling the development of groundbreaking solutions in medical science.

Conclusion

Chiu-Yueh Chen stands out as an inventor with significant contributions to the medical field through his patented innovations. His disintegrin variants represent a promising step toward effective treatments for osteoporosis and related conditions. The collaborations he has fostered within leading academic institutions confirm the importance of teamwork in achieving remarkable advancements in healthcare.